首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1379086

2023-2028 年神经復健设备市场报告（按产品类型、应用、最终用户和地区）

Neurorehabilitation Devices Market Report by Product Type, Application, End User, and Region 2023-2028

出版日期: 2023年11月02日 | 出版商:

IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

抽象的

2022年全球神经復健器材市场规模达17亿美元。展望未来， IMARC Group预计到2028年市场规模将达到31亿美元，2022-2028年复合年增长率（CAGR）为10.5%。

神经復健设备是指用于检查大脑和中枢神经系统（CNS）的设备。一些常用的设备包括神经机器人系统、非侵入性脑刺激器、神经假体、脑机介面和穿戴式装置。这些设备有助于诊断和治疗患者神经系统的疾病、病症或损伤。它们有助于重新学习运动技能和神经系统疾病（如帕金森氏症和心血管中风）的最佳恢復。因此，神经復健设备在各种诊所、认知护理和研究机构以及医疗中心得到了广泛的应用。

神经復健设备市场趋势：

多发性硬化症、帕金森氏症和脑性麻痹等神经系统疾病的盛行率不断上升，是推动市场成长的关键因素之一。此外，老年人口的增加更容易患此类疾病，这也推动了市场的成长。神经復健设备有助于将多样化的电讯号传送到脊髓的多条纤维，以恢復肢体运动。此外，各种技术进步，例如透过虚拟实境（VR）、机器人技术和人工智慧（AI）将復健活动游戏化，有助于促进康復，也是其他促进成长的因素。与此一致的是，利用新型多电极刺激治疗脊髓损伤也促进了市场的成长。其他因素，包括大众医疗保健支出能力的提高，以及广泛的研发（R＆D）活动，预计将进一步推动市场。

本报告回答的关键问题

2022年全球神经復健器材市场规模有多大？
2023-2028年全球神经復健器材市场的预期成长率是多少？
推动全球神经復健设备市场的关键因素是什么？
COVID-19 对全球神经復健设备市场有何影响？
根据产品类型，全球神经復健设备市场的细分如何？
基于应用的全球神经復健设备市场的细分情况如何？
基于最终用户的全球神经復健设备市场的细分情况如何？
全球神经復健器材市场的重点区域有哪些？
全球神经復健设备市场的主要参与者/公司有哪些？

北美洲
- 美国
  - 市场走向
  - 市场预测
- 加拿大
  - 市场走向
  - 市场预测
亚太
- 中国
  - 市场走向
  - 市场预测
- 日本
  - 市场走向
  - 市场预测
- 印度
  - 市场走向
  - 市场预测
- 韩国
  - 市场走向
  - 市场预测
- 澳洲
  - 市场走向
  - 市场预测
- 印尼
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
欧洲
- 德国
  - 市场走向
  - 市场预测
- 法国
  - 市场走向
  - 市场预测
- 英国
  - 市场走向
  - 市场预测
- 义大利
  - 市场走向
  - 市场预测
- 西班牙
  - 市场走向
  - 市场预测
- 俄罗斯
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
拉丁美洲
- 巴西
  - 市场走向
  - 市场预测
- 墨西哥
  - 市场走向
  - 市场预测
- 其他的
  - 市场走向
  - 市场预测
中东和非洲
- 市场走向
- 按国家/地区分類的市场细分
- 市场预测

第 10 章：SWOT 分析

概述
优势
弱点
机会
威胁

第 11 章：价值链分析

第 12 章：波特五力分析

概述
买家的议价能力
供应商的议价能力
竞争程度
新进入者的威胁
替代品的威胁

第 13 章：价格分析

第14章：竞争格局

市场结构
关键参与者
关键参与者简介
- Biometrics Ltd
- Bioness Inc.
- Bionik Laboratories Corp
- BioXtreme Ltd.
- Boston Scientific Corporation
- Ectron Ltd
- Ekso Bionics
- Hocoma AG (DIH International Limited)
- Kinestica
- Kinova Inc.
- Medtronic plc
- Saebo Inc
- Tyromotion GmbH

简介目录图表

Product Code: SR112023A4005

Abstract

The global neurorehabilitation devices market size reached US$ 1.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 10.5% during 2022-2028.

Neurorehabilitation devices refer to the equipment used for examination of the brain and central nervous system (CNS). Some of the commonly used devices include neurorobotic systems, non-invasive brain stimulators, neuroprosthetics, brain-computer interfaces and wearable devices. These devices assist in the diagnosis and treatment of a disease, disorder or injury in the nervous system of the patient. They facilitate in re-learning motor skills and optimal recovery from neurological disorders, such as Parkinson's disease, and cardiovascular stroke. As a result, neurorehabilitation devices find extensive applications across various clinics, cognitive care and research institutes and healthcare centers.

Neurorehabilitation Devices Market Trends:

The increasing prevalence of neurological diseases, such as multiple sclerosis, Parkinson's disease and cerebral palsy, is one of the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the growth of the market. Neurorehabilitation devices aid in deploying diversified electric signals to multiple fibers of the spinal cord for the recovery of limb movements. Additionally, various technological advancements, such as the gamification of rehabilitation activities through virtual reality (VR), robotics and artificial intelligence (AI), that aid in promoting recovery are acting as other growth-inducing factors. In line with this, the utilization of novel multi-electrode stimulation for the treatment of spinal cord injuries is also contributing to the market growth. Other factors, including rising healthcare expenditure capacities of the masses, along with extensive research and development (R&D) activities, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global neurorehabilitation devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, application and end user.

Breakup by Product Type:

Neurorobotic Devices

Wearable Devices

Non-Invasive Stimulators

Brain-Computer Interface

Breakup by Application:

Stroke

Multiple Sclerosis

Parkinson's Disease

Cerebral Palsy

Others

Breakup by End User:

Hospitals and Clinics

Cognitive Care Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Biometrics Ltd, Bioness Inc., Bionik Laboratories Corp, BioXtreme Ltd., Boston Scientific Corporation, Ectron Ltd, Ekso Bionics, Hocoma AG (DIH International Limited), Kinestica, Kinova Inc., Medtronic plc, Saebo Inc and Tyromotion GmbH.

Key Questions Answered in This Report

1. What was the size of the global neurorehabilitation devices market in 2022?
2. What is the expected growth rate of the global neurorehabilitation devices market during 2023-2028?
3. What are the key factors driving the global neurorehabilitation devices market?
4. What has been the impact of COVID-19 on the global neurorehabilitation devices market?
5. What is the breakup of the global neurorehabilitation devices market based on the product type?
6. What is the breakup of the global neurorehabilitation devices market based on the application?
7. What is the breakup of the global neurorehabilitation devices market based on the end user?
8. What are the key regions in the global neurorehabilitation devices market?
9. Who are the key players/companies in the global neurorehabilitation devices market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Neurorehabilitation Devices Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type

6.1 Neurorobotic Devices
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Wearable Devices
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Non-Invasive Stimulators
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Brain-Computer Interface
- 6.4.1 Market Trends
- 6.4.2 Market Forecast

7 Market Breakup by Application

7.1 Stroke
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Multiple Sclerosis
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Parkinson's Disease
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Cerebral Palsy
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by End User

8.1 Hospitals and Clinics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Cognitive Care Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Biometrics Ltd
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
- 14.3.2 Bioness Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
- 14.3.3 Bionik Laboratories Corp
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
- 14.3.4 BioXtreme Ltd.
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
- 14.3.5 Boston Scientific Corporation
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Ectron Ltd
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
- 14.3.7 Ekso Bionics
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
- 14.3.8 Hocoma AG (DIH International Limited)
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
- 14.3.9 Kinestica
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
- 14.3.10 Kinova Inc.
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
- 14.3.11 Medtronic plc
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials
  - 14.3.11.4 SWOT Analysis
- 14.3.12 Saebo Inc
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio
- 14.3.13 Tyromotion GmbH
  - 14.3.13.1 Company Overview
  - 14.3.13.2 Product Portfolio
  - 14.3.13.3 Financials

简介目录图表

List of Figures

Figure 1: Global: Neurorehabilitation Devices Market: Major Drivers and Challenges
Figure 2: Global: Neurorehabilitation Devices Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Neurorehabilitation Devices Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Neurorehabilitation Devices Market: Breakup by Product Type (in %), 2022
Figure 5: Global: Neurorehabilitation Devices Market: Breakup by Application (in %), 2022
Figure 6: Global: Neurorehabilitation Devices Market: Breakup by End User (in %), 2022
Figure 7: Global: Neurorehabilitation Devices Market: Breakup by Region (in %), 2022
Figure 8: Global: Neurorehabilitation Devices (Neurorobotic Devices) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Neurorehabilitation Devices (Neurorobotic Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Neurorehabilitation Devices (Wearable Devices) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Neurorehabilitation Devices (Wearable Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Neurorehabilitation Devices (Non-Invasive Stimulators) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Neurorehabilitation Devices (Non-Invasive Stimulators) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Neurorehabilitation Devices (Brain-Computer Interface) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Neurorehabilitation Devices (Brain-Computer Interface) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Neurorehabilitation Devices (Stroke) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Neurorehabilitation Devices (Stroke) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Neurorehabilitation Devices (Multiple Sclerosis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Neurorehabilitation Devices (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Neurorehabilitation Devices (Parkinson's Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Neurorehabilitation Devices (Parkinson's Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Neurorehabilitation Devices (Cerebral Palsy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Neurorehabilitation Devices (Cerebral Palsy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Neurorehabilitation Devices (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Neurorehabilitation Devices (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Neurorehabilitation Devices (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Neurorehabilitation Devices (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Neurorehabilitation Devices (Cognitive Care Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Neurorehabilitation Devices (Cognitive Care Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Neurorehabilitation Devices (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Neurorehabilitation Devices (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: North America: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: North America: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: United States: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: United States: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Canada: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Canada: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Asia-Pacific: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Asia-Pacific: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: China: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: China: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Japan: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Japan: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: India: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: India: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: South Korea: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: South Korea: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Australia: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Australia: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Indonesia: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Indonesia: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Others: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Others: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Europe: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Europe: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Germany: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Germany: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: France: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: France: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: United Kingdom: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: United Kingdom: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Italy: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Italy: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Spain: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Spain: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Russia: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Russia: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Others: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Others: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Latin America: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Latin America: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Brazil: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Brazil: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Mexico: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Mexico: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Middle East and Africa: Neurorehabilitation Devices Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: Middle East and Africa: Neurorehabilitation Devices Market: Breakup by Country (in %), 2022
Figure 80: Middle East and Africa: Neurorehabilitation Devices Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Global: Neurorehabilitation Devices Industry: SWOT Analysis
Figure 82: Global: Neurorehabilitation Devices Industry: Value Chain Analysis
Figure 83: Global: Neurorehabilitation Devices Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Neurorehabilitation Devices Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Neurorehabilitation Devices Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
Table 3: Global: Neurorehabilitation Devices Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: Neurorehabilitation Devices Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 5: Global: Neurorehabilitation Devices Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Neurorehabilitation Devices Market: Competitive Structure
Table 7: Global: Neurorehabilitation Devices Market: Key Players

02-2729-4219

+886-2-2729-4219